These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 22292984)

  • 1. Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion.
    Wu ZS; Wang CQ; Xiang R; Liu X; Ye S; Yang XQ; Zhang GH; Xu XC; Zhu T; Wu Q
    BMC Cancer; 2012 Feb; 12():51. PubMed ID: 22292984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
    Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H
    Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-339-5p inhibits breast cancer cell migration and invasion in vitro and may be a potential biomarker for breast cancer prognosis.
    Wu ZS; Wu Q; Wang CQ; Wang XN; Wang Y; Zhao JJ; Mao SS; Zhang GH; Zhang N; Xu XC
    BMC Cancer; 2010 Oct; 10():542. PubMed ID: 20932331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.
    Chiyomaru T; Enokida H; Tatarano S; Kawahara K; Uchida Y; Nishiyama K; Fujimura L; Kikkawa N; Seki N; Nakagawa M
    Br J Cancer; 2010 Mar; 102(5):883-91. PubMed ID: 20160723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-133a acts as a tumour suppressor in breast cancer through targeting LASP1.
    Sui Y; Zhang X; Yang H; Wei W; Wang M
    Oncol Rep; 2018 Feb; 39(2):473-482. PubMed ID: 29207145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-21: A gene of dual regulation in breast cancer.
    Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
    Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10.
    Chen Y; Zhang J; Wang H; Zhao J; Xu C; Du Y; Luo X; Zheng F; Liu R; Zhang H; Ma D
    BMC Cancer; 2012 Mar; 12():111. PubMed ID: 22439757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin-bundling protein 1.
    Lai C; Chen Z; Li R
    Mol Med Rep; 2015 Jul; 12(1):1473-8. PubMed ID: 25815687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-133a inhibits cervical cancer growth by targeting EGFR.
    Song X; Shi B; Huang K; Zhang W
    Oncol Rep; 2015 Sep; 34(3):1573-80. PubMed ID: 26134491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer.
    Yang Q; Yu Y; Sun Z; Pan Y
    Biomed Pharmacother; 2018 Oct; 106():61-67. PubMed ID: 29957467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway.
    Cui W; Zhang S; Shan C; Zhou L; Zhou Z
    FEBS J; 2013 Aug; 280(16):3962-74. PubMed ID: 23786162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met.
    Wu ZS; Wu Q; Wang CQ; Wang XN; Huang J; Zhao JJ; Mao SS; Zhang GH; Xu XC; Zhang N
    Cancer; 2011 Jul; 117(13):2842-52. PubMed ID: 21692045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor role of miR-133a in gastric cancer by repressing IGF1R.
    Gong Y; Ren J; Liu K; Tang LM
    World J Gastroenterol; 2015 Mar; 21(10):2949-58. PubMed ID: 25780292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression.
    Mansoori B; Mohammadi A; Ghasabi M; Shirjang S; Dehghan R; Montazeri V; Holmskov U; Kazemi T; Duijf P; Gjerstorff M; Baradaran B
    J Cell Physiol; 2019 Jun; 234(6):9816-9825. PubMed ID: 30480817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-mediated silencing of miR-133a-3p promotes breast cancer cell migration and stemness via miR-133a-3p/MAML1/DNMT3A positive feedback loop.
    Shi W; Tang T; Li X; Deng S; Li R; Wang Y; Wang Y; Xia T; Zhang Y; Zen K; Jin L; Pan Y
    J Exp Clin Cancer Res; 2019 Oct; 38(1):429. PubMed ID: 31660998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer.
    Qin Y; Dang X; Li W; Ma Q
    Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
    Wang J; Wang S; Zhou J; Qian Q
    Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.